Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

zirconium Zr 89 anti-CD8 antibody ZED88082A

A radioimmunoconjugate consisting of an antibody targeting the human CD8 antigen on CD8-positive (CD8+) T cells and labeled with the radioisotope zirconium Zr 89, with potential imaging activity using positron emission tomography (PET). Upon administration, the antibody moiety of ZED88082A specifically targets and binds to the CD8 antigen expressed on T cells. This allows for visualization of CD8+ T cells upon imaging using PET. CD8+ T cells are effector cells involved in the immune response against tumor cells and play a key role in the eradication of tumor cells.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:89Zr anti-CD8 antibody ZED88082A
zirconium Zr 89-labeled anti-CD8 imaging agent ZED88082A
Zr-89 anti-CD8 antibody ZED88082A
Code name:ZED88082A
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search